These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14697086)

  • 1. [Inclusion of health-related quality of life studies alongside clinical trials: basis and practical recommendations. Utilization of a check-list for their correct desing and evaluation].
    Soto Alvarez J
    An Med Interna; 2003 Dec; 20(12):633-44. PubMed ID: 14697086
    [No Abstract]   [Full Text] [Related]  

  • 2. The art of choosing sound study endpoints.
    Hanson B
    Injury; 2008 Jun; 39(6):656-8. PubMed ID: 18514657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
    D'Haens G; Sandborn WJ; Feagan BG; Geboes K; Hanauer SB; Irvine EJ; Lémann M; Marteau P; Rutgeerts P; Schölmerich J; Sutherland LR
    Gastroenterology; 2007 Feb; 132(2):763-86. PubMed ID: 17258735
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic analysis alongside clinical trials: practical considerations. The Economics Workgroup.
    Drummond M; O'Brien B
    J Rheumatol; 1995 Jul; 22(7):1418-9. PubMed ID: 7562789
    [No Abstract]   [Full Text] [Related]  

  • 5. Health-related quality of life measurement in symptom management trials.
    Ganz PA; Goodwin PJ
    J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis assessment tools in clinical trials.
    Feldman SR; Krueger GG
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii65-8; discussion ii69-73. PubMed ID: 15708941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy.
    Pandya A; Berneburg M; Ortonne JP; Picardo M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():21-8. PubMed ID: 17176301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instruments for quality of life assessment in patients with gastrointestinal cancer.
    Pallis AG; Mouzas IA
    Anticancer Res; 2004; 24(3b):2117-21. PubMed ID: 15274411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
    Revicki D; Hays RD; Cella D; Sloan J
    J Clin Epidemiol; 2008 Feb; 61(2):102-9. PubMed ID: 18177782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral health-related quality of life: a broader perspective.
    Al Shamrany M
    East Mediterr Health J; 2006 Nov; 12(6):894-901. PubMed ID: 17333837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.
    Buchanan DR; O'Mara AM; Kelaghan JW; Sgambati M; McCaskill-Stevens W; Minasian L
    Cancer; 2007 Oct; 110(7):1621-8. PubMed ID: 17868120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The design of clinical studies in neurooncology].
    Smolin AV; Kobiakov GL
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (1):3-10. PubMed ID: 18491424
    [No Abstract]   [Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005.
    Rogers SN; Ahad SA; Murphy AP
    Oral Oncol; 2007 Oct; 43(9):843-68. PubMed ID: 17600755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
    Reed SD; Anstrom KJ; Bakhai A; Briggs AH; Califf RM; Cohen DJ; Drummond MF; Glick HA; Gnanasakthy A; Hlatky MA; O'Brien BJ; Torti FM; Tsiatis AA; Willan AR; Mark DB; Schulman KA
    Am Heart J; 2005 Mar; 149(3):434-43. PubMed ID: 15864231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and cancer.
    Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):9-11. PubMed ID: 19371172
    [No Abstract]   [Full Text] [Related]  

  • 20. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
    Bottomley A; Aaronson NK;
    J Clin Oncol; 2007 Nov; 25(32):5082-6. PubMed ID: 17991925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.